StonvexLoading…
StonvexStonvexStonvexCore line items from GEVO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $42.95M | $160.58M | $115.23M | $72.52M |
Operating Income | $-4.90M | $-20.21M | $-18.03M | $-14.34M |
Net Income | $-21.70M | $-33.84M | $-27.54M | $-19.58M |
EPS (Diluted) | $-0.09 | $-0.14 | $-0.12 | $-0.08 |
Total Assets | $653.50M | $718.93M | $685.21M | $702.12M |
Total Liabilities | $198.80M | $247.76M | $210.38M | $222.35M |
Cash & Equivalents | $78.90M | $81.16M | $72.60M | $57.26M |
Free Cash Flow OCF − CapEx | $-30.02M | $-43.51M | $-52.26M | $-37.65M |
Shares Outstanding | 243.07M | 242.46M | 242.12M | 241.84M |